Implant Sciences Adds Middle East to Growing List of QS-B220 Deployments

Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it shipped units of its Quantum Sniffer(TM) QS-B220 benchtop explosives and narcotics trace detectors. The shipments include a previously announced sale of a distributor demonstration system to China.

Continuing the Company's recent success with non-government users, the latest customer is a corporation in the Middle East that is integrating trace detection into its building security operations. To date, QS-B220s have been sold to customers in Asia, Europe, the Middle East and North America for use in a variety of corporate and government applications including public safety, VIP security, and corporate security.

Since its introduction last year, the QS-B220 has received both CE Certification and ASTM E2520 Certification. The product is currently being evaluated for certification by the U.S. Transportation Security Administration for air cargo screening.

Related Research on

C4ISR Market - Global Forecast to 2022

"The QS-B220 is enjoying growing market acceptance due to its ease of use, wide range of explosives and drugs detection capabilities, and freedom from radioactive materials. Currently we are selling to corporate and governmental buyers for non-regulated applications as we move forward with certification processes required to participate in other market segments," stated Implant Sciences' Global Vice President of Sales and Marketing Darryl Jones. "This product greatly expands the global market the Company participates in and we believe it has the potential to far outpace sales of our handheld QS-H150 unit."

Source: Implant Sciences Corp.
Date: May 30, 2012